IC
NKTR icon

IEQ Capital’s Nektar Therapeutics NKTR Stock Holding History

IEQ Capital’s Portfolio NKTR Stock Details NKTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$906K Buy
+12,978
New +$950K ﹤0.01% 1135
2025
Q3 		– Sell
-38,255
Closed -$989K – 2002
2025
Q2 		$989K Buy
38,255
+1,107
+3% +$12.4K 0.01% 866
2025
Q1 		$379K Buy
37,148
+35,683
+2,436% +$466K ﹤0.01% 1096
2024
Q4 		$20.4K Hold
1,465
– – ﹤0.01% 1320
2024
Q3 		$28.6K Hold
1,465
– – ﹤0.01% 1143
2024
Q2 		$27.3K Sell
1,465
-145
-9% -$3.06K ﹤0.01% 986
2024
Q1 		$22.6K Buy
1,610
+704
+78% +$7.37K ﹤0.01% 963
2023
Q4 		$7.68K Buy
906
+133
+17% +$1.01K ﹤0.01% 924
2023
Q3 		$6.91K Hold
773
– – ﹤0.01% 937
2023
Q2 		$6.67K Hold
773
– – ﹤0.01% 896
2023
Q1 		$8.15K Hold
773
– – ﹤0.01% 888
2022
Q4 		$26.2K Sell
773
-3,786
-83% -$183K ﹤0.01% 805
2022
Q3 		$219K Sell
4,559
-300
-6% -$17.8K 0.01% 747
2022
Q2 		$277K Sell
4,859
-26
-0.5% -$1.64K 0.01% 624
2022
Q1 		$395K Buy
4,885
+15
+0.3% +$2.22K 0.01% 563
2021
Q4 		$987K Buy
4,870
+3,779
+346% +$820K 0.02% 310
2021
Q3 		$294K Buy
+1,091
New +$262K 0.01% 562
2021
Q1 		– Sell
-17,771
Closed -$4.53M – 491
2020
Q4 		$4.53M Buy
+17,771
New +$4.59M 0.2% 83

Other funds holding NKTR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

IEQ Capital's NKTR Position: Q2 2026 in Review

IEQ Capital opened a new position in Nektar Therapeutics (NKTR) in Q2 2026: 12,978 shares worth $906K. The stake represents ﹤0.01% of the portfolio and ranks #1135 among its holdings. This is a return to the name: IEQ Capital previously reported a position in NKTR as recently as Q2 2025.

IEQ Capital first reported a position in NKTR in Q4 2020 and has held it in 18 quarters since. The position peaked at $4.53M in Q4 2020. 240 funds tracked by Wall St. Rank hold NKTR as of Q2 2026.

  • IEQ Capital held 12,978 shares of Nektar Therapeutics worth $906K as of Q2 2026.
  • Nektar Therapeutics was a new IEQ Capital position in Q2 2026.
  • Nektar Therapeutics made up ﹤0.01% of IEQ Capital's portfolio in Q2 2026, its #1135 holding.
  • IEQ Capital first reported a position in Nektar Therapeutics in Q4 2020 and has held it in 18 quarters since.
  • IEQ Capital's Nektar Therapeutics position peaked at $4.53M in Q4 2020.
  • 240 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q2 2026.

Based on IEQ Capital's 13F filing for Q2 2026, filed 11 Aug 2026.